Akero Therapeutics (AKRO) PT Raised to $73 at Canaccord Genuity
Tweet Send to a Friend
(Updated - January 28, 2025 6:35 AM EST)
Canaccord Genuity analyst Edward Nash raised the price target on Akero ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst Edward Nash raised the price target on Akero ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
